Riskpilot← Back to searchSign inGet full accessTriolab Oy
OYActiveY-tunnus 0629706-0Mustionkatu 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 1986— employeeswww.triolab.fi
Revenue 2024
EUR 22,7M
EBITDA margin
21.2%
Equity ratio
154.8%
Financial strength
Net profit 2024
EUR 3,7M
| Revenue | EUR 22,7M | — |
| EBITDA | EUR 4,8M | — |
| Net profit | EUR 3,7M | — |
| Total assets | EUR 4M | — |
| Equity | EUR 6,1M | — |
| Employees | — | — |
Legal name
Triolab Oy
Y-tunnus number
0629706-0
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. heinäkuuta 1986
Share capital
EUR 9 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet kaksi yhdessä
Company purpose
Föremålet för bolagets verksamhet är att importera och driva handel med laboratoriereagenser och -instrument.
Address
Mustionkatu 2
Phone
+3580201226600
Email
info@triolab.fi
Website
www.triolab.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 28 438 | 28 836 | 24 765 | 0 | 22 728 |
| Staff expenses | −2 926 | −3 039 | −3 071 | −0 | −13 044 |
| EBITDA | 8 528 | 8 386 | 6 444 | 0 | 4 810 |
| Depreciation & amort. | −290 | −225 | −204 | −0 | −190 |
| EBIT | 8 238 | 8 161 | 6 240 | 0 | 4 621 |
| Net financials | −6 | −1 | 9 | 0 | −0 |
| Profit before tax | 8 231 | 8 159 | 6 248 | 0 | 4 621 |
| Tax | 1 646 | 1 634 | 1 253 | −0 | 962 |
| Net profit | 6 585 | 6 525 | 4 995 | 0 | 3 659 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 029 | 11 941 | 9 911 | 0 | 3 961 |
| Equity | 7 577 | 7 702 | 6 197 | 0 | 6 134 |
| Long-term debt | 250 | 257 | 183 | 0 | 0 |
| Short-term debt | 4 201 | 3 982 | 3 531 | 0 | 3 682 |
| Total debt | 4 452 | 4 239 | 3 714 | 0 | 3 682 |
EBITDA margin
21.2%
This company
15.8%
Market median
+34% vs market
20202024
Equity ratio
154.8%
This company
38.2%
Market median
+305% vs market
20202024
Return on equity
59.6%
This company
18.4%
Market median
+224% vs market
20202024
Net profit margin
16.1%
This company
8.1%
Market median
+99% vs market
20202024
Asset turnover
5.74×
This company
1.12×
Market median
+413% vs market
20202024
Debt / equity
-0.35×
This company
0.62×
Market median
+156% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AM Chief Executive Officer | Chief Executive Officer | 2025 |
JS Deputy Member | Deputy Member | 2025 |
| Former (1) | ||
NV Audit | Audit | 2014 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairperson | 2020 | |
| Former (3) | ||
| Board of Directors | 2018 – 2020 | |
| Chairperson | 2018 – 2020 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Triolab Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Maria Bergström | Chief Executive Officer | 0 companies |
| Jussi Sakari Kurittu | Deputy Member | 0 companies |
| Niklas Vilhelm Oikia | Audit | 0 companies |
| Tove Elisabeth Hauge Nyhus | Board of Directors | 0 companies |
| Neel Bock Noel Larsen | Board of Directors | 0 companies |
| Kai Tapani Rantanen | Chairperson | 0 companies |
| Rolf Ove Stefan Sandin | Chairperson | 0 companies |
| Gert Pynt Andersen | Board of Directors | 0 companies |